12 healthcare stocks move in Friday's after-market session
Winners Shares of Passage Bio PASG rose 7.7% to $2.66 in Friday's aftermarket session. The market value of their outstanding shares is $144.4 million. Shares of vTv Therapeutics VTVT rose 7.65% to $0.7. The market value of their outstanding shares is $54.5 million. Shares of Cabaletta Bio CABA rose 7.45% to $1.73. The market value of their outstanding shares is $50.1 million. Shares of NeuroBo Pharmaceuticals NRBO rose 6.69% to $0.59. The company's market cap is $15.7 million. Astria Therapeutics ATXS stock rose 5.37% to $3.92. The market value of their outstanding shares is $51.0 million. Shares of Viking Therapeutics VKTX rose 4.98% to $3.58. The company's market cap is $276.9 million. losers SINTX Technologies SINT stock fell 12.6% to $0.4 in Friday's aftermarket session. The market value of their outstanding shares is $9.7 million. Macrogenics MGNX stock fell 8.58% to $3.2. This security traded at a volume of 65,100 shares approaching it, representing 5.5% of its average volume over the past 100 days. The market value of their outstanding shares is $196.2 million. Titan Pharmaceuticals TTNP stock fell 6.48% to $1.3. At the close, Titan Pharmaceuticals' trading volume reached 59.8,000 shares. This represents 7.9% of its average volume over the last 100 days. The company's market capitalization is $19.0 million. Cyclerion Therapeutics' CYCN stock fell 6.25% to $0.68. The company's market cap is $29.5 million. Shares of Kazia Therapeutics KZIA fell 5.41% to $3.85. The company's market cap is $53.4 million. Shares of Syros Pharmaceuticals SYRS fell 5.0% to $0.83. The company's market cap is $52.4 million. See also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
![12 healthcare stocks move in Friday's after-market session](https://cdn.benzinga.com/files/imagecache/600x400xUP/images/story/2022/movers_image_12186.jpeg?#)
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
What's Your Reaction?
![like](https://vidianews.com/assets/img/reactions/like.png)
![dislike](https://vidianews.com/assets/img/reactions/dislike.png)
![love](https://vidianews.com/assets/img/reactions/love.png)
![funny](https://vidianews.com/assets/img/reactions/funny.png)
![angry](https://vidianews.com/assets/img/reactions/angry.png)
![sad](https://vidianews.com/assets/img/reactions/sad.png)
![wow](https://vidianews.com/assets/img/reactions/wow.png)